Hemp Wars On the Way?

October 11, 2023 · Green Market Report

The exploding national U.S. hemp market has ballooned to more than $28 billion in revenue this year alone, surpassing the national marijuana market in total value, according to economist Beau Whitney.

Driving most of that growth is the “cannabinoid” sector, which is a polite way of categorizing both non-intoxicating CBD products as well as intoxicating goods made with various versions of THC molecules, such as delta-8.

That boom has overshadowed hemp’s more traditional industrial uses, and thus the markets themselves for hemp fibers and grains, Whitney warned, because federal regulators have pivoted their focus to regulating cannabinoids instead of issuing agricultural permits for more industrial hemp farms.

“The average U.S. hemp farm in 2022 was 17.1 acres. In order to support one million acres of demand for hemp, the U.S. would require 58,480 licenses to be issued. That is equal to issuing 160 licenses per day,” Whitney wrote in a newsletter this week. “Will the farm bill provide funding to support this explosive growth, or will its focus on cannabinoids be an obstacle for this emerging industry?”

Hemp grain and fiber business opportunities were cut off to the tune of $20 billion since the start of 2022, Whitney calculated, due to a “one size fits all policy” from federal regulators on hemp business issues.

That’s led to even more clamoring from business interests for federal guidance and prioritization, which could naturally then lead to more serious competition among stakeholders in the hemp trade for any advantage that could be gained from an audience with Washington, D.C. officials.

So are some version of hemp wars on the way within the booming sector, in the same manner that much of the marijuana trade has turned more cutthroat in recent years?

It seems like a safe bet. (Full Story)

In category:Hemp
Next Post

Alaska marijuana regulator to oversee some hemp-derived products

Certain hemp-derived products in Alaska will now be regulated by the state’s marijuana regulatory agency under new rules passed by lawmakers. The change doesn’t affect all hemp products, only derivatives containing intoxicating delta-8 or delta-9 THC as well as some “so-called ‘full-spectrum’…
Previous Post

USDA Approves Low-THC Hemp Plants for U.S. Production, Breeding

A team of researchers and scientists have created what can be thought of as diet hemp plants, or plants that have been modified to produce less THC than the minimal amount hemp plants already do. It turns out the same…
Random Post

Progress not happening fast enough for marijuana social equity entrepreneurs

Arizona, Illinois and Michigan were among a handful of states over the past year where Black entrepreneurs opened marijuana stores in key markets. In March, Nuggets Dispensary became the first Black-owned business with a marijuana social equity retail license to open in Detroit,…
Random Post

$5.7 Billion in Tax Revenue in the Last 18 Months and Anti-Pot Groups Worry the Weed Biz Would Get Too Big with Rescheduling?

Eleven former high-ranking officials, including six ex-DEA heads and five former White House drug czars, have opposed the U.S. Department of Health and Human Services' recommendation to reschedule marijuana. They sent a letter to the current Attorney General and DEA Administrator,…
Random Post

Nevada Senators Discuss Psilocybin Legalization Bill In Committee, Including Amendment To Increase Possession Limit

Nevada senators held a hearing on a bill to legalize the possession of psilocybin on Thursday, discussing a proposed amendment to remove therapeutic use provisions and taking extensive testimony from advocates and experts—including from an Assembly lawmaker who shared his…
Random Post

Australia Legalizes Psilocybin And MDMA Prescriptions As U.S. Patients Seek Similar Authorization

The Australian government has rescheduled the psychedelics psilocybin and MDMA to provide access to people with post-traumatic stress disorder (PTSD) and treat-resistant depression. The substances aren’t being legalized for broad use, but by placing them in Schedule 8 for therapeutic…